Ontaneda D - Search Results

1

A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis.

Daboul L, O'Donnell CM, Amin M, Rodrigues P, Derbyshire J, Azevedo C, Bar-Or A, Caverzasi E, Calabresi PA, Cree BA, Freeman L, Henry RG, Longbrake EE, Oh J, Papinutto N, Pelletier D, Prchkovska V, Raza P, Ramos M, Samudralwar RD, Schindler MK, Sotirchos ES, Sicotte NL, Solomon AJ, Shinohara RT, Reich DS, Sati P, Ontaneda D. Daboul L, et al. Among authors: ontaneda d. Mult Scler. 2024 Jan;30(1):25-34. doi: 10.1177/13524585231214360. Epub 2023 Dec 13. Mult Scler. 2024. PMID: 38088067 Free PMC article.

2

Race/ethnic differences in AD survival in us Alzheimer's disease centers.

Ontaneda D. Ontaneda D. Neurology. 2009 May 5;72(18):1619; author reply 1620. doi: 10.1212/01.wnl.0000346326.51499.be. Neurology. 2009. PMID: 19414733 No abstract available.

3

Metabolic syndrome in small fiber sensory neuropathy.

Zhou L, Li J, Ontaneda D, Sperling J. Zhou L, et al. Among authors: ontaneda d. J Clin Neuromuscul Dis. 2011 Jun;12(4):235-43. doi: 10.1097/CND.0b013e3182196e3c. J Clin Neuromuscul Dis. 2011. PMID: 22361523

4

The benefits and risks of alemtuzumab in multiple sclerosis.

Ontaneda D, Cohen JA. Ontaneda D, et al. Expert Rev Clin Immunol. 2013 Mar;9(3):189-91. doi: 10.1586/eci.13.1. Expert Rev Clin Immunol. 2013. PMID: 23445192 No abstract available.

5

Stem cell injection-induced glioneuronal lesion of the cauda equina.

Lee BS, Achey RL, Yeaney GA, Bosler DS, Aly Z, Ontaneda D, Morren J, Benzel EC. Lee BS, et al. Among authors: ontaneda d. Neurology. 2018 Mar 27;90(13):613-615. doi: 10.1212/WNL.0000000000005219. Epub 2018 Feb 23. Neurology. 2018. PMID: 29476035 No abstract available.

6

Neuroemergencies in South America: How to Fill in the Gaps?

Silva GS, Maldonado NJ, Mejia-Mantilla JH, Ortega-Gutierrez S, Claassen J, Varelas P, Suarez JI; Galapagos Neurocritical Care Summit Investigators. Silva GS, et al. Neurocrit Care. 2019 Dec;31(3):573-582. doi: 10.1007/s12028-019-00775-8. Neurocrit Care. 2019. PMID: 31342447

7

Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon.

Skromne E, Rivera VM, Ontaneda D, Ordonez L. Skromne E, et al. Among authors: ontaneda d. Neurology. 2006 Jun 13;66(11):1787-8; author reply 1787-8. doi: 10.1212/01.wnl.0000230563.29202.6a. Neurology. 2006. PMID: 16769975 No abstract available.

8

Vitamin D Levels and Visual System Measurements in Progressive Multiple Sclerosis: A Cross-sectional Study.

Abbatemarco JR, Fox RJ, Li H, Bermel RA, Ontaneda D. Abbatemarco JR, et al. Among authors: ontaneda d. Int J MS Care. 2021 Mar-Apr;23(2):53-58. doi: 10.7224/1537-2073.2020-005. Epub 2020 Apr 28. Int J MS Care. 2021. PMID: 33880080 Free PMC article.

9

Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.

Ontaneda D, LaRocca N, Coetzee T, Rudick R; NMSS MSFC Task Force. Ontaneda D, et al. Mult Scler. 2012 Aug;18(8):1074-80. doi: 10.1177/1352458512451512. Epub 2012 Jun 27. Mult Scler. 2012. PMID: 22740488

10

Propensity methods for multiple sclerosis: The devil is in the details.

Ontaneda D, Love TE. Ontaneda D, et al. Mult Scler. 2016 Sep;22(10):1248-9. doi: 10.1177/1352458516660390. Epub 2016 Jul 13. Mult Scler. 2016. PMID: 27411702 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters